Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1983-05-26
1985-06-25
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514422, 514414, 548465, 548467, 548518, 548550, 546208, C07D40306, C07D40106, C07D20709, A61K 3140
Patent
active
045254761
ABSTRACT:
N-[1-oxo-3-(5-oxo-2-pyrrolidinyl)propyl]-alpha-aminoacids, base addition salts, esters, and amides are useful as cognition activators. Pharmaceutical compositions containing these compounds and methods of using the pharmaceutical compositions for treating senility or amnesia are also disclosed.
REFERENCES:
patent: 3459738 (1969-08-01), Morren et al.
patent: 4144246 (1979-03-01), L'Italien et al.
patent: 4145347 (1979-03-01), L'Italien et al.
patent: 4372966 (1983-02-01), Butler
Colonge et al., Bul. Soc. Chim. France, vol. 3, (1962), pp. 598-603.
Leonard et al., J. Am. Chem. Soc., vol. 69, (1947), pp. 690-692.
Butler Donald E.
Hershenson Fred M.
Pavia Michael R.
Daus Donald G.
Janssen Jerry F.
Teoli, Jr. W. A.
Warner-Lambert & Company
LandOfFree
N-[1-oxo-3-(5-oxo-2-pyrrolidinyl)propyl]-alpha-aminoacids and de does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-[1-oxo-3-(5-oxo-2-pyrrolidinyl)propyl]-alpha-aminoacids and de, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-[1-oxo-3-(5-oxo-2-pyrrolidinyl)propyl]-alpha-aminoacids and de will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-554995